Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: Morphological, immunohistochemical, and gene expression profiles-Reference-Cited by-同舟云学术

Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: Morphological, immunohistochemical, and gene expression profiles

Published:2010-11-17 Issue:8 Volume:71 Page:846-856
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Aparicio Ana,Tzelepi Vasiliki,Araujo John C.,Guo Charles C.,Liang Shoudan,Troncoso Patricia,Logothetis Christopher J.,Navone Nora M.,Maity Sankar N.

Publisher

Wiley

Subject

Urology,Oncology

Reference33 articles.

1. Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms;Li;J Clin Invest,2008

2. Molecular characterization of prostatic small-cell neuroendocrine carcinoma;Clegg;Prostate,2003

3. Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 cases;Tetu;Cancer,1987

4. Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate;Papandreou;J Clin Oncol,2002

5. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study;Turbat-Herrera;Arch Pathol Lab Med,1988

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-Derived Models of Cancer in the NCI PDMC Consortium: Selection, Pitfalls, and Practical Recommendations;Cancers;2024-01-29

2. Unveiling novel insights in prostate cancer through single-cell RNA sequencing;Frontiers in Oncology;2023-09-08

3. The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer;Cancer Research Communications;2023-08-03

4. Preclinical Models of Neuroendocrine Neoplasia;Cancers;2022-11-17

5. Adipose triglyceride lipase is regulated by CAMKK2-AMPK signaling and drives advanced prostate cancer;2022-11-03